165 related articles for article (PubMed ID: 28598634)
1. Design and Synthesis of γ- and δ-Lactam M
Davoren JE; Garnsey M; Pettersen B; Brodney MA; Edgerton JR; Fortin JP; Grimwood S; Harris AR; Jenkinson S; Kenakin T; Lazzaro JT; Lee CW; Lotarski SM; Nottebaum L; O'Neil SV; Popiolek M; Ramsey S; Steyn SJ; Thorn CA; Zhang L; Webb D
J Med Chem; 2017 Aug; 60(15):6649-6663. PubMed ID: 28598634
[TBL] [Abstract][Full Text] [Related]
2. PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems.
Moran SP; Cho HP; Maksymetz J; Remke DH; Hanson RM; Niswender CM; Lindsley CW; Rook JM; Conn PJ
ACS Chem Neurosci; 2018 Sep; 9(9):2218-2224. PubMed ID: 29683646
[TBL] [Abstract][Full Text] [Related]
3. An Approach to Discovering Novel Muscarinic M
Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
[TBL] [Abstract][Full Text] [Related]
4. T-495, a novel low cooperative M
Mandai T; Sako Y; Kurimoto E; Shimizu Y; Nakamura M; Fushimi M; Maeda R; Miyamoto M; Kimura H
Pharmacol Res Perspect; 2020 Feb; 8(1):e00560. PubMed ID: 31990455
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M
Engers JL; Bender AM; Kalbfleisch JJ; Cho HP; Lingenfelter KS; Luscombe VB; Han C; Melancon BJ; Blobaum AL; Dickerson JW; Rook JM; Niswender CM; Emmitte KA; Conn PJ; Lindsley CW
ACS Chem Neurosci; 2019 Mar; 10(3):1035-1042. PubMed ID: 30086237
[TBL] [Abstract][Full Text] [Related]
6. Diverse Effects on M
Rook JM; Abe M; Cho HP; Nance KD; Luscombe VB; Adams JJ; Dickerson JW; Remke DH; Garcia-Barrantes PM; Engers DW; Engers JL; Chang S; Foster JJ; Blobaum AL; Niswender CM; Jones CK; Conn PJ; Lindsley CW
ACS Chem Neurosci; 2017 Apr; 8(4):866-883. PubMed ID: 28001356
[TBL] [Abstract][Full Text] [Related]
7. A Novel M
Rook JM; Bertron JL; Cho HP; Garcia-Barrantes PM; Moran SP; Maksymetz JT; Nance KD; Dickerson JW; Remke DH; Chang S; Harp JM; Blobaum AL; Niswender CM; Jones CK; Stauffer SR; Conn PJ; Lindsley CW
ACS Chem Neurosci; 2018 Sep; 9(9):2274-2285. PubMed ID: 29701957
[TBL] [Abstract][Full Text] [Related]
8. M
Moran SP; Dickerson JW; Cho HP; Xiang Z; Maksymetz J; Remke DH; Lv X; Doyle CA; Rajan DH; Niswender CM; Engers DW; Lindsley CW; Rook JM; Conn PJ
Neuropsychopharmacology; 2018 Jul; 43(8):1763-1771. PubMed ID: 29581537
[TBL] [Abstract][Full Text] [Related]
9. Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects.
Davoren JE; Lee CW; Garnsey M; Brodney MA; Cordes J; Dlugolenski K; Edgerton JR; Harris AR; Helal CJ; Jenkinson S; Kauffman GW; Kenakin TP; Lazzaro JT; Lotarski SM; Mao Y; Nason DM; Northcott C; Nottebaum L; O'Neil SV; Pettersen B; Popiolek M; Reinhart V; Salomon-Ferrer R; Steyn SJ; Webb D; Zhang L; Grimwood S
J Med Chem; 2016 Jul; 59(13):6313-28. PubMed ID: 27275946
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M
Mandai T; Kasahara M; Kurimoto E; Tanaka M; Suzuki M; Nakatani A; Kimura H
Neuroscience; 2019 Aug; 414():60-76. PubMed ID: 31299348
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism.
Bridges TM; Rook JM; Noetzel MJ; Morrison RD; Zhou Y; Gogliotti RD; Vinson PN; Xiang Z; Jones CK; Niswender CM; Lindsley CW; Stauffer SR; Conn PJ; Daniels JS
Drug Metab Dispos; 2013 Sep; 41(9):1703-14. PubMed ID: 23821185
[TBL] [Abstract][Full Text] [Related]
12. SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs).
Kuduk SD; Beshore DC
Curr Top Med Chem; 2014; 14(15):1738-54. PubMed ID: 25176125
[TBL] [Abstract][Full Text] [Related]
13. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
[TBL] [Abstract][Full Text] [Related]
14. Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey.
Vardigan JD; Cannon CE; Puri V; Dancho M; Koser A; Wittmann M; Kuduk SD; Renger JJ; Uslaner JM
Psychopharmacology (Berl); 2015 Jun; 232(11):1859-66. PubMed ID: 25491927
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
van der Westhuizen ET; Spathis A; Khajehali E; Jörg M; Mistry SN; Capuano B; Tobin AB; Sexton PM; Scammells PJ; Valant C; Christopoulos A
Mol Pharmacol; 2018 Jul; 94(1):770-783. PubMed ID: 29691279
[TBL] [Abstract][Full Text] [Related]
16. Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease.
Chintamaneni PK; Krishnamurthy PT; Rao PV; Pindiprolu SS
Med Hypotheses; 2017 Apr; 101():17-22. PubMed ID: 28351483
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M
Dallagnol JCC; Khajehali E; van der Westhuizen ET; Jörg M; Valant C; Gonçalves AG; Capuano B; Christopoulos A; Scammells PJ
J Med Chem; 2018 Apr; 61(7):2875-2894. PubMed ID: 29544056
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Optimization of Potent and CNS Penetrant M
Bender AM; Cho HP; Nance KD; Lingenfelter KS; Luscombe VB; Gentry PR; Voigtritter K; Berizzi AE; Sexton PM; Langmead CJ; Christopoulos A; Locuson CW; Bridges TM; Chang S; O'Neill JC; Zhan X; Niswender CM; Jones CK; Conn PJ; Lindsley CW
ACS Chem Neurosci; 2018 Jul; 9(7):1572-1581. PubMed ID: 29678111
[TBL] [Abstract][Full Text] [Related]
19. TAK-071, a novel M
Sako Y; Kurimoto E; Mandai T; Suzuki A; Tanaka M; Suzuki M; Shimizu Y; Yamada M; Kimura H
Neuropsychopharmacology; 2019 Apr; 44(5):950-960. PubMed ID: 30089885
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M
Spearing PK; Cho HP; Luscombe VB; Blobaum AL; Boutaud O; Engers DW; Rodriguez AL; Niswender CM; Jeffrey Conn P; Lindsley CW; Bender AM
Bioorg Med Chem Lett; 2021 Sep; 47():128193. PubMed ID: 34118412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
